ECSP003696A - SYNTHETIC COMBINATIONS OF AN NK1 RECEIVER ANTAGONIST AND A GABA STRUCTURAL ANALOG - Google Patents

SYNTHETIC COMBINATIONS OF AN NK1 RECEIVER ANTAGONIST AND A GABA STRUCTURAL ANALOG

Info

Publication number
ECSP003696A
ECSP003696A ECSP003696A ECSP003696A EC SP003696 A ECSP003696 A EC SP003696A EC SP003696 A ECSP003696 A EC SP003696A EC SP003696 A ECSP003696 A EC SP003696A
Authority
EC
Ecuador
Prior art keywords
structural analog
synthetic combinations
gaba
antagonist
receiver antagonist
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Lakhbir Singh
John Hughes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003696 priority Critical patent/ECSP003696A/en
Publication of ECSP003696A publication Critical patent/ECSP003696A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención proporciona métodos de tratamiento usando combinaciones sinergísticas de un antagonista de receptor de NK1 y un análogo de GABA y composicioones farmacéuticas y productos que contienen al antagonista de receptor de NK1 y el análogo de GABA. La p resente invención también proporciona el uso de una natgonista de receptor de NK1 y un análogo de GABA para la fabricación de un medicamento para el tratamiento o la prevención del dolor crónico.The present invention provides methods of treatment using synergistic combinations of an NK1 receptor antagonist and a GABA analog and pharmaceutical compositions and products containing the NK1 receptor antagonist and the GABA analog. The present invention also provides the use of a NK1 receptor natgonist and a GABA analog for the manufacture of a medicament for the treatment or prevention of chronic pain.

ECSP003696 2000-10-06 2000-10-06 SYNTHETIC COMBINATIONS OF AN NK1 RECEIVER ANTAGONIST AND A GABA STRUCTURAL ANALOG ECSP003696A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003696 ECSP003696A (en) 2000-10-06 2000-10-06 SYNTHETIC COMBINATIONS OF AN NK1 RECEIVER ANTAGONIST AND A GABA STRUCTURAL ANALOG

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003696 ECSP003696A (en) 2000-10-06 2000-10-06 SYNTHETIC COMBINATIONS OF AN NK1 RECEIVER ANTAGONIST AND A GABA STRUCTURAL ANALOG

Publications (1)

Publication Number Publication Date
ECSP003696A true ECSP003696A (en) 2001-03-22

Family

ID=42041285

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003696 ECSP003696A (en) 2000-10-06 2000-10-06 SYNTHETIC COMBINATIONS OF AN NK1 RECEIVER ANTAGONIST AND A GABA STRUCTURAL ANALOG

Country Status (1)

Country Link
EC (1) ECSP003696A (en)

Similar Documents

Publication Publication Date Title
DE69734006D1 (en) PROCESS FOR RELAXING PAIN THROUGH A COMBINATION OF TRAMADOL AND A NMDA ANTAGONIST
PT954314E (en) FORMS OF PHARMACEUTICAL DOSAGE FOR IMPROVING MALE ERECTILE DYSFUNCTION
AR032132A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMBINATION OF A TRAMADOL COMPOUND AND ANTI-CONVULSIVE DRUG AND USE OF THE COMBINATION TO PREPARE A MEDICINAL PRODUCT
UY26376A1 (en) SYNTHETIC COMBINATIONS OF AN NK1 ANTAGONIST AND A GABA STRUCTURAL ANALOG
BR0015188A (en) Pharmaceutical compositions
NO20053104D0 (en) Oral, extended-release analgesic dosage form for administration ± once per day. day.
AR023806A1 (en) USE OF A PEPTIDE MIXTURE FOR THE MANUFACTURE OF A THERAPEUTIC AGENT FOR PROFILAXIS AND / OR CANCER TREATMENT, PHARMACEUTICAL COMPOSITIONS AND VACCINES CONTAINING SUCH MIXTURE AND THE PROCEDURES FOR PREPARATION OF THESE COMPOSITIONS
MX2022015629A (en) USE OF VIBEGRON TO TREAT OVERACTIVE BLADDER.
EP0934065A4 (en) PHARMACEUTICAL COMPOUNDS
HRP20070476T3 (en) Treatment of dependence withdrawal
MX2007000117A (en) A COMBINATION COMPOSITION.
AR023687A1 (en) A COMPOSITION FOR THE TREATMENT OF EXTERNAL RETINA DISORDERS AND THE USE OF A GLUTAMATE ANTAGONIST FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF EXTERNAL RETINA DISORDERS
BRPI0411347A (en) therapeutic combinations comprising pde inhibitors and vasopressin receptor antagonists for the treatment of dysmenorrhea
HUP0202847A2 (en) Synergetic insecticidal and acaricidal active ingredient combinations preparation and use thereof
ECSP003696A (en) SYNTHETIC COMBINATIONS OF AN NK1 RECEIVER ANTAGONIST AND A GABA STRUCTURAL ANALOG
DOP2000000076A (en) SYNTHETIC COMBINATIONS OF AN NK1 RECEIVER ANTAGONIST AND A GABA STRUCTURAL ANALOG. (SYNERGISTIC COMBINATIONS OF A NKI RECEIVER ANTAGONIST AND A GABA STRUCTURAL ANALOG)
ATE233745T1 (en) MEDICINAL SUBSTANCES
SV2002000189A (en) SYNTHETIC COMBINATIONS OF AN NK1 RECEIVER ANTAGONIST AND A GABA STRUCTURAL ANALOG
PT942729E (en) UTILIZATION OF NK-1 RECEPTOR ANTAGONISTS FOR TREATMENT OF STRESSE DISEASES
BR0311141A (en) Synergistically interaction of abacavir and alovudine
AR018825A1 (en) ANTIGONISTS OF THE NON-PEPTIDIC BRADIQUININE RECEPTOR FOR USE IN THE TREATMENT OF DISORDERS AND OPHTHALMIC DISEASES
BR0311209A (en) Method of producing pharmaceutical dosage units for oral administration, use of etonogestrel, and tablet
PE20011042A1 (en) USE OF GLUTAMINE FOR THE PREVENTION OF LATE ONSET DIARRHEA INDUCED BY IRINOTECAN
ES2063079T3 (en) A PHARMACEUTICAL COMPOSITION THAT HAS A SYNERGIC EFFECT BASED ON SULBACTAM AND METAMPICILLINE.
AR027152A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COGNITIVE CEREBROVASCULAR DISEASE.